Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$120M |
| 2 |
Apple
AAPL
|
+$107M |
| 3 |
Medtronic
MDT
|
+$99.1M |
| 4 |
AGN
Allergan plc
AGN
|
+$98.7M |
| 5 |
Qualcomm
QCOM
|
+$91.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$166M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$111M |
| 3 |
AT&T
T
|
+$78.6M |
| 4 |
Yum! Brands
YUM
|
+$57.6M |
| 5 |
PNC Financial Services
PNC
|
+$49.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.93% |
| 2 | Technology | 13.76% |
| 3 | Financials | 13.26% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
John Wiley & Sons Class A
WLY
$2.52B
| $7.35M | 0.01% |
120,192
-189,150
| -61% | -$11.6M |
|
1227
InterDigital
IDCC
$8.72B
| $7.34M | 0.01% |
144,721
+14,331
| +11% | +$744K |
|
|
KATE
1228
DELISTED
Kate Spade & Company
KATE
| $7.33M | 0.01% |
219,621
+24,132
| +12% | +$764K |
|
1229
Telephone and Data Systems
TDS
$3.84B
| $7.32M | 0.01% |
294,037
+28,140
| +11% | +$703K |
|
|
ANAC
1230
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $7.31M | 0.01% |
126,350
+8,297
| +7% | +$352K |
|
1231
Papa John's
PZZA
$801M
| $7.3M | 0.01% |
118,171
+9,328
| +9% | +$581K |
|
|
MWW
1232
DELISTED
Monster Worldwide Inc
MWW
| $7.3M | 0.01% |
1,152,051
+130,555
| +13% | +$716K |
|
|
GEVA
1233
DELISTED
SYNAGEVA BIOPHARMA CORP COM STK (DE)
GEVA
| $7.3M | 0.01% |
74,869
+16,952
| +29% | +$1.79M |
|
1234
Clearwater Paper
CLW
$366M
| $7.29M | 0.01% |
111,714
+396
| +0.4% | +$26.4K |
|
1235
Korn Ferry
KFY
$4.25B
| $7.28M | 0.01% |
221,356
+5,400
| +3% | +$164K |
|
1236
Core Laboratories
CLB
$570M
| $7.28M | 0.01% |
69,623
-568
| -0.8% | -$60.5K |
|
|
NATI
1237
DELISTED
National Instruments Corp
NATI
| $7.27M | 0.01% |
226,887
+27,314
| +14% | +$848K |
|
1238
Royal Gold
RGLD
$19.8B
| $7.26M | 0.01% |
115,005
+9,907
| +9% | +$681K |
|
1239
Genesco
GCO
$409M
| $7.23M | 0.01% |
101,541
+13,161
| +15% | +$955K |
|
1240
Rayonier
RYN
$6.45B
| $7.23M | 0.01% |
295,552
+42,428
| +17% | +$1.08M |
|
1241
Mercury Insurance
MCY
$5.86B
| $7.18M | 0.01% |
124,359
+24,765
| +25% | +$1.39M |
|
1242
Nelnet
NNI
$4.48B
| $7.16M | 0.01% |
151,389
+5,313
| +4% | +$245K |
|
|
AEC
1243
DELISTED
ASSOCIATED ESTATES REALTY CORP
AEC
| $7.16M | 0.01% |
290,152
+28,627
| +11% | +$702K |
|
1244
Invesco Mortgage Capital
IVR
$802M
| $7.15M | 0.01% |
46,063
+4,660
| +11% | +$726K |
|
1245
National Health Investors
NHI
$3.39B
| $7.15M | 0.01% |
100,628
+7,669
| +8% | +$554K |
|
1246
Timken Company
TKR
$8.91B
| $7.14M | 0.01% |
169,415
+21,898
| +15% | +$908K |
|
1247
Armstrong World Industries
AWI
$7.89B
| $7.14M | 0.01% |
124,171
+6,254
| +5% | +$335K |
|
1248
Mueller Water Products
MWA
$4.09B
| $7.12M | 0.01% |
722,479
-15,843
| -2% | -$152K |
|
|
TIME
1249
DELISTED
Time Inc.
TIME
| $7.11M | 0.01% |
316,596
+20,512
| +7% | +$491K |
|
|
SFG
1250
DELISTED
STANCORP FINL GRP
SFG
| $7.1M | 0.01% |
103,484
+13,168
| +15% | +$876K |
|
Similar funds
Charles Schwab's Q1 2015 Portfolio in Review
As of Q1 2015, Charles Schwab held 3,139 positions worth $71.1B, up 6.7% from $66.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Charles Schwab deployed $3.65B of net new capital in Q1 2015, opening 29 new positions and adding to 2,392 existing holdings. Its largest new stake was Qorvo: 519,290 shares worth $41.4M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was AT&T, an estimated $78.6M trimmed.
- Charles Schwab's largest Q1 2015 buy was Qorvo: 519,290 shares worth $41.4M.
- Charles Schwab added most to IBM in Q1 2015, an estimated $120M increase.
- Charles Schwab's biggest Q1 2015 reduction was AT&T, cutting an estimated $78.6M.
- Charles Schwab fully exited Allergan Inc in Q1 2015, selling an estimated $166M.
- Charles Schwab's ten largest holdings make up 14% of its $71.1B portfolio in Q1 2015.
- Charles Schwab opened 29 new positions and closed 57 in Q1 2015.
- Charles Schwab's portfolio value rose 6.7% quarter-over-quarter to $71.1B.
Based on Charles Schwab's 13F filing for Q1 2015, filed 14 May 2015.